Hyeonjeong K. Kang

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD.

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 28, 2024

Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib.

Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib.

Journal: Cancers

Published: September 13, 2021

State-of-Art of Cellular Therapy for Acute Leukemia.

State-of-Art of Cellular Therapy for Acute Leukemia.

Journal: International journal of molecular sciences

Published: April 05, 2021

Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production.

Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production.

Journal: Blood

Published: September 09, 2020

CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy.

CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy.

Journal: Blood

Published: November 08, 2019

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade.

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 26, 2018

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15.

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15.

Journal: Journal for immunotherapy of cancer

Published: July 23, 2018

Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer.

Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 20, 2018

Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy.

Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 01, 2018

Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms.

Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 31, 2017

Supplementation of direct-fed microbials as an alternative to antibiotic on growth performance, immune response, cecal microbial population, and ileal morphology of broiler chickens.

Supplementation of direct-fed microbials as an alternative to antibiotic on growth performance, immune response, cecal microbial population, and ileal morphology of broiler chickens.

Journal: Poultry science

Published: July 23, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026